An updated flow chart for the evaluation of chorea
Objective: The aim of this poster is to provide a tool to facilitate diagnosis of chorea. This flow chart has been presented at previous MDS…Post-stroke movement disorders: an analysis of 24 cases
Objective: To define prevalence of post-stroke movement disorders and correlate their clinical presentation with infarct localisation. Background: Stroke related movement disorders are rare, they can…Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort
Objective: To compare baseline clinical and imaging characteristics of the GBA and LRRK2 PD manifest cohorts to PD sporadic (sPD) cohort. Background: The phenotype and…Clinical and imaging characteristics of non-manifest LRRK2 and GBA carriers: The PPMI cohort
Objective: To examine baseline clinical and dopamine transporter (DAT) imaging characteristics in a cohort of non-manifest carriers (NMC) of GBA and LRRK2 compared to healthy…Experimental model of developing of Parkinson’s disease
Objective: Analyzing the reserpine model of Parkinsonian syndrome Background: There are several experimental models of Parkinson's disease: reserpine, methamphetamine, 6-hydroxydopamine (6-OHDA), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine - substances that…Movement disorders after stroke in the third Moroccan level hospital, Marrakech
Objective: The goal of this study is to describe the clinical, paraclinical and evolutive features of patients having suffered a movement disorder in the aftermath…Generalized chorea in a patient with isolated leukocytosis and JAK2V617F mutation: A case report
Objective: To describe late-onset generalized chorea in a patient found to have the JAK2V617F mutation without polycythemia vera. Background: Polycythemia vera (PV) is well-known to…Elevated serum α-synuclein levels in Huntington’s disease patients
Objective: To investigate serum α-synuclein levels in Huntington’s disease (HD) patients. Background: HD is a heredodegenerative disease caused by mutations in HTT coding for huntingtin…Parallel evaluation of mutant huntingtin and neurofilament light in Huntington’s disease
Objective: To assess cerebrospinal fluid (CSF) mutant Huntingtin (mHTT), and CSF and plasma neurofilament light (NfL) in Huntington’s disease (HD). Background: HD is a progressive…Neurofilament light protein: An emerging clinical and translational biofluid biomarker for Huntington’s disease
Objective: To investigate whether neurofilament light protein (NfL) a potential prognostic marker of neurodegeneration with Huntington’s disease. Background: NfL, a component of the axonal cytoskeleton,…
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- Next Page »